Axq Capital, LP Bristol Myers Squibb CO Transaction History

Axq Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $2.09 Million - $2.75 Million	51,983 New	51,983 $2.16 Billion
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $276,336 - $329,745	5,700 New	5,700 $292 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.6 Million - $1.78 Million	-25,190 Reduced 86.0%	4,100 $262 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $729,249 - $827,133	11,098 Added 61.0%	29,290 $2.03 Billion
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $1.25 Million - $1.48 Million	18,192 New	18,192 $1.31 Billion

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.